Literature DB >> 29256019

Fuhrman grading is inappropriate for papillary renal cell carcinoma.

Brett Delahunt1, Lars Egevad2, John R Srigley3, Hemamali Samaratunga4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29256019     DOI： 10.1007/s00345-017-2153-y

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


× No keyword cloud information.
  10 in total

1.  The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.

Authors:  Brett Delahunt; John C Cheville; Guido Martignoni; Peter A Humphrey; Cristina Magi-Galluzzi; Jesse McKenney; Lars Egevad; Ferran Algaba; Holger Moch; David J Grignon; Rodolfo Montironi; John R Srigley
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.

Authors:  Julien Dagher; Brett Delahunt; Nathalie Rioux-Leclercq; Lars Egevad; John R Srigley; Geoffrey Coughlin; Nigel Dunglinson; Troy Gianduzzo; Boon Kua; Greg Malone; Ben Martin; John Preston; Morgan Pokorny; Simon Wood; John Yaxley; Hemamali Samaratunga
Journal:  Histopathology       Date:  2017-10-02       Impact factor: 5.087

3.  Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.

Authors:  Dianne Sika-Paotonu; Peter B Bethwaite; Margaret R E McCredie; T William Jordan; Brett Delahunt
Journal:  Am J Surg Pathol       Date:  2006-09       Impact factor: 6.394

4.  Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.

Authors:  H Borgmann; M Musquera; A Haferkamp; A Vilaseca; T Klatte; S F Shariat; A Scavuzzo; M A Jimenez Rios; I Wolff; U Capitanio; P Dell'Oglio; L M Krabbe; E Herrmann; T Ecke; D Vergho; N Huck; N Wagener; S Pahernik; S Zastrow; M Wirth; C Surcel; C Mirvald; K Prochazkova; G Hutterer; R Zigeuner; L Cindolo; M Hora; C G Stief; M May; S D Brookman-May
Journal:  World J Urol       Date:  2017-08-23       Impact factor: 4.226

5.  Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.

Authors:  Brett Delahunt; Dianne Sika-Paotonu; Peter B Bethwaite; Thomas William Jordan; Cristina Magi-Galluzzi; Ming Zhou; Hemamali Samaratunga; John R Srigley
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

6.  Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma.

Authors:  William R Sukov; Christine M Lohse; Bradley C Leibovich; R Houston Thompson; John C Cheville
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

Review 7.  Advances and controversies in grading and staging of renal cell carcinoma.

Authors:  Brett Delahunt
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

8.  A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis.

Authors:  Brett Delahunt; Jesse K McKenney; Christine M Lohse; Bradley C Leibovich; Robert Houston Thompson; Stephen A Boorjian; John C Cheville
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

Review 9.  Gleason and Fuhrman no longer make the grade.

Authors:  Brett Delahunt; Lars Egevad; Hemamali Samaratunga; Guido Martignoni; John N Nacey; John R Srigley
Journal:  Histopathology       Date:  2015-11-16       Impact factor: 5.087

10.  Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma.

Authors:  Tobias Klatte; Christine Anterasian; Jonathan W Said; Michela de Martino; Fairooz F Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Journal:  J Urol       Date:  2010-06       Impact factor: 7.600
  10 in total
  3 in total

1.  External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.

Authors:  Stefan Zastrow; Laura-Maria Krabbe; Ingmar Wolff; Umberto Capitanio; Tobias Klatte; Thorsten Ecke; Nina Huck; Hendrik Borgmann; Anna Scavuzzo; Luca Cindolo; Luigi Schips; Cristian Surcel; Cristian Mirvald; Antoni Vilaseca Cabo; Mireia Musquera; Georg Hutterer; Kristyna Prochazkova; Christian Stief; Manfred Wirth; Matthias May; Sabine Brookman-May
Journal:  Int J Clin Oncol       Date:  2019-08-30       Impact factor: 3.402

2.  Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma.

Authors:  Xiang Le; Xiang-Bo Wang; Hao Zhao; Ren-Fu Chen; Peng Ge
Journal:  BMC Urol       Date:  2020-09-15       Impact factor: 2.264

3.  Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery.

Authors:  Xiang Tu; Fan Wang; Tiancong Chang; Chichen Zhang; Mengni Zhang; Zhenhua Liu; Shi Qiu; Lu Yang; Qiang Wei
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.